Frontiers in Oncology | Hematologic Malignancies

Original Research

Published on 10 Aug 2023

Characterization of engraftment dynamics in myelofibrosis after allogeneic hematopoietic cell transplantation including novel conditioning schemes

in Hematologic Malignancies

Sarah Jungius
Franziska C. Adam
Kerstin Grosheintz
Michael Medinger
Andreas Buser
Jakob R. Passweg
Jörg P. Halter
Sara C. Meyer

Frontiers in Oncology

doi 10.3389/fonc.2023.1205387

2,970 views

Brief Research Report

Published on 03 Aug 2023

SARS-CoV-2 infection in high-risk children following tixagevimab–cilgavimab (Evusheld) pre-exposure prophylaxis: a single-center observational study

in Hematologic Malignancies

Diego R. Hijano
Jose A. Ferrolino
Elizabeth G. Swift
Carolyn A. Michaels
Anita Max
Randall T. Hayden
Joshua Wolf
Ronald H. Dallas
William L. Greene
Julie L. Richardson

Frontiers in Oncology

doi 10.3389/fonc.2023.1229655

2,388 views
3 citations

Brief Research Report

Published on 03 Aug 2023

“Waitlist mortality” is high for myeloma patients with limited access to BCMA therapy

in Hematologic Malignancies

Nausheen Ahmed
William Wesson
Muhammad Umair Mushtaq
Rajat Bansal
Haitham AbdelHakim
Sarah Bromert
Allison Appenfeller
Batool Abu Ghazal
Anurag Singh
Sunil Abhyankar

Frontiers in Oncology

doi 10.3389/fonc.2023.1206715

3,471 views
7 citations

Opinion

Published on 03 Aug 2023

A smoking gun? Clonal expansion in response to cigarette exposure

in Hematologic Malignancies

Daniel I. Nathan
John Mascarenhas

Frontiers in Oncology

doi 10.3389/fonc.2023.1252643

1,303 views

Mini Review

Published on 03 Aug 2023

Therapeutic targeting of leukemia stem cells in acute myeloid leukemia

in Hematologic Malignancies

Karina Barbosa
Aniruddha J. Deshpande

Frontiers in Oncology

doi 10.3389/fonc.2023.1204895

5,648 views
5 citations

Original Research

Published on 03 Aug 2023

Machine learning models-based on integration of next-generation sequencing testing and tumor cell sizes improve subtype classification of mature B-cell neoplasms

in Hematologic Malignancies

Yafei Mu
Yuxin Chen
Yuhuan Meng
Tao Chen
Xijie Fan
Jiecheng Yuan
Junwei Lin
Jianhua Pan
Guibin Li
Jinghua Feng

Frontiers in Oncology

doi 10.3389/fonc.2023.1160383

1,922 views
1 citation

Original Research

Published on 03 Aug 2023

Monoclonal antibodies binding to different epitopes of CD20 differentially sensitize DLBCL to different classes of chemotherapy

in Hematologic Malignancies

Brian Lee
Tim Pierpont
Avery August
Kristy Richards

Frontiers in Oncology

doi 10.3389/fonc.2023.1159484

3,184 views

Review

Published on 03 Aug 2023

Management of chronic myelogenous leukemia with COVID-19 and hepatitis B

in Hematologic Malignancies

Tian Yu
Weiming Li
Tao Yu

Frontiers in Oncology

doi 10.3389/fonc.2023.1217023

2,128 views

Editorial

Published on 01 Aug 2023

Editorial: New emerging functions of transcription factors and RNA-binding proteins in the development of hematological malignancies

in Hematologic Malignancies

Tarik Möröy
Cyrus Khandanpour

Frontiers in Oncology

doi 10.3389/fonc.2023.1256461

1,174 views

Editorial

Published on 01 Aug 2023

Editorial: 50 years of BMT: long-term outcomes and late complications after transplantation

in Hematologic Malignancies

Eleni Gavriilaki

Frontiers in Oncology

doi 10.3389/fonc.2023.1253971

1,083 views
2 citations

Editorial

Published on 31 Jul 2023

Editorial: Risk factors in multiple myeloma identified before and during treatment: are we ready to personalize treatment?

in Hematologic Malignancies

Mattia D’Agostino
Carolina Terragna
Mark van Duin

Frontiers in Oncology

doi 10.3389/fonc.2023.1247808

1,719 views
2 citations

Editorial

Published on 25 Jul 2023

Editorial: Precision medicine for acute myeloid leukemia

in Hematologic Malignancies

Giovanni Marconi
Fabio Guolo
Jacopo Nanni
Cristina Papayannidis

Frontiers in Oncology

doi 10.3389/fonc.2023.1233757

1,879 views

Original Research

Published on 24 Jul 2023

Impact of interval progression before autologous stem cell transplant in patients with multiple myeloma

in Hematologic Malignancies

Alicia Bao
Qiuhong Zhao
Ruchi Kudalkar
Jose Rodriguez
Nidhi Sharma
Naresh Bumma
Srinivas S. Devarakonda
Abdullah M. Khan
Elvira Umyarova
Ashley E. Rosko

Frontiers in Oncology

doi 10.3389/fonc.2023.1216461

3,103 views
1 citation

Original Research

Published on 21 Jul 2023

Clinical and genetic characteristics in lymphoma patients with a second solid malignancy

in Hematologic Malignancies

Di Zhou
Leng Han
Chanjuan Jin
Lintao Bi

Frontiers in Oncology

doi 10.3389/fonc.2023.1152290

2,241 views
1 citation

Original Research

Published on 21 Jul 2023

Calcineurin-independent NFATc1 signaling is essential for survival of Burkitt lymphoma cells

in Hematologic Malignancies

Krisna Murti
Hendrik Fender
Carolin Glatzle
Rhoda Wismer
Salvador Sampere-Birlanga
Vanessa Wild
Khalid Muhammad
Andreas Rosenwald
Edgar Serfling
Andris Avots

Frontiers in Oncology

doi 10.3389/fonc.2023.1205788

3,398 views

Original Research

Published on 21 Jul 2023

Cigarette smoke stimulates clonal expansion of Jak2V617F and Tet2-/- cells

in Hematologic Malignancies

Gajalakshmi Ramanathan
Jane H. Chen
Nitya Mehrotra
Tiffany Trieu
Aaron Huang
Eduard Mas
Jessica E. Monterrosa Mena
Bishop Bliss
David A. Herman
Michael T. Kleinman

Frontiers in Oncology

doi 10.3389/fonc.2023.1210528

4,195 views
8 citations